Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
暂无分享,去创建一个
A. Wagner | M. Ausems | P. Manders | R. Sijmons | N. Hoogerbrugge | L. van der Kolk | C. Aalfs | A. Mensenkamp | A. Cats | Frederik J Hes | Nicoline Hoogerbrugge | Anja Wagner | F. Hes | Annemieke Cats | Rolf Sijmons | Rachel S van der Post | Lizet E van der Kolk | J Han van Krieken | R. S. van der Post | Arjen R Mensenkamp | Cora M Aalfs | Margreet G E M Ausems | Peggy Manders | L. V. van Hest | Encarna B Gómez García | Ingrid P Vogelaar | Liselotte P van Hest | Neeltje Arts | Marjolijn J L Ligtenberg | I. P. Vogelaar | J. V. van Krieken | M. Ligtenberg | N. Arts | E. G. Gómez Garcia | A. Wagner
[1] L. Aaltonen,et al. A germline E-cadherin mutation in a family with gastric and colon cancer. , 2001, International journal of molecular medicine.
[2] A. Sézeur,et al. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study , 2013, Journal of Medical Genetics.
[3] Christopher B. Burge,et al. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.
[4] A. Jemal,et al. Global Cancer Statistics , 2011 .
[5] A. Spurdle,et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.
[6] J. Yokota,et al. Familial gastric cancer: overview and guidelines for management* , 1999, Journal of medical genetics.
[7] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[8] B. Friedenson. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. , 2005, MedGenMed : Medscape general medicine.
[9] F. Roviello,et al. High Incidence of Familial Gastric Cancer in Tuscany, a Region in Italy , 2008, Oncology.
[10] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[11] Carla Oliveira,et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. , 2003, Human molecular genetics.
[12] H. Grönberg,et al. Germline mutations in E‐cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer , 2002, International journal of cancer.
[13] W F Bodmer,et al. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea , 2000, Gut.
[14] H. Höfler,et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. , 1999, The American journal of pathology.
[15] B. Bonanni,et al. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome , 2014, Genes, chromosomes & cancer.
[16] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[17] J. Lennerz,et al. Endoscopic Surveillance of Patients With Hereditary Diffuse Gastric Cancer: Biopsy Recommendations After Topographic Distribution of Cancer Foci in a Series of 10 CDH1-mutated Gastrectomies , 2012, The American journal of surgical pathology.
[18] B. Boman,et al. Identification of seven novel germline mutations in the human E‐cadherin (CDH1) Gene , 2007, Human mutation.
[19] L. Aaltonen,et al. Screening E‐cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred , 2002, Human mutation.
[20] R. Bernards,et al. An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer , 2013, The Journal of pathology.
[21] Kylie L. Gorringe,et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. , 1998, Cancer research.
[22] R. van Hillegersberg,et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers , 2015, Journal of Medical Genetics.
[23] J. Coebergh,et al. Gastric cancer: Decreasing incidence but stable survival in the Netherlands , 2014, Acta oncologica.
[24] R. Seruca,et al. A model to infer the pathogenic significance of CDH1 germline missense variants , 2006, Journal of Molecular Medicine.
[25] G. Lee,et al. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients , 2012, Familial Cancer.
[26] C. la Vecchia,et al. Family history and the risk of stomach and colorectal cancer , 1992, Cancer.
[27] O. Olopade,et al. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers , 2010, Journal of Medical Genetics.
[28] R. Jeffrey,et al. Risk-reducing Total Gastrectomy for Germline Mutations in E-cadherin (CDH1): Pathologic Findings With Clinical Implications , 2008, The American journal of surgical pathology.
[29] R. Seruca,et al. E-cadherin mutations and cell motility: a genotype-phenotype correlation. , 2009, Experimental cell research.
[30] L. Serrano,et al. E-Cadherin Destabilization Accounts for the Pathogenicity of Missense Mutations in Hereditary Diffuse Gastric Cancer , 2012, PloS one.
[31] I. Choi,et al. Association of family history with cancer recurrence and survival in patients with gastric cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Simpson,et al. Germline CDH1 mutations in bilateral lobular carcinoma in situ , 2013, British Journal of Cancer.
[33] R. Seruca,et al. Genetics, Pathology, and Clinics of Familial Gastric Cancer , 2006, International journal of surgical pathology.
[34] T. Yasuda,et al. Family history of cancer in Japanese gastric cancer patients , 2007, Gastric Cancer.
[35] J. Fraumeni,et al. Gastric cancer in individuals with Li-Fraumeni syndrome , 2011, Genetics in Medicine.
[36] S. Beghelli,et al. Family history of gastric cancer: a correlation between epidemiologic findings and clinical data , 2005, Gastric Cancer.
[37] Larry N. Singh,et al. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. , 2012, American journal of human genetics.
[38] Anthony E. Reeve,et al. E-cadherin germline mutations in familial gastric cancer , 1998, Nature.
[39] D. de Jong,et al. CDH1‐related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling , 2012, International journal of cancer.
[40] D. Huntsman,et al. Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management , 2005, Clinical Cancer Research.
[41] P. Guilford,et al. Hereditary diffuse gastric cancer: A manifestation of lost cell polarity , 2009, Cancer science.
[42] H. Höfler,et al. Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients , 2004, Journal of Medical Genetics.
[43] G. Berx,et al. The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.
[44] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[45] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[46] A. Zharkikh,et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.
[47] I. V. van Rooij,et al. Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. , 2013, Human molecular genetics.
[48] Markus Loeffler,et al. Risks of less common cancers in proven mutation carriers with lynch syndrome. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] David Haussler,et al. Improved splice site detection in Genie , 1997, RECOMB '97.
[50] F. Zambrana,et al. Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention , 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[51] P. Miron,et al. Germline E-cadherin mutations in familial lobular breast cancer , 2007, Journal of Medical Genetics.
[52] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[53] M. Unno,et al. Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis. , 2013, The Tohoku journal of experimental medicine.
[54] D. Chung,et al. Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer. , 2007, The New England journal of medicine.
[55] B. Fernandez,et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. , 2007, JAMA.
[56] W. Foulkes,et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.
[57] C. Caldas,et al. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. , 2014, Gastrointestinal endoscopy.
[58] E. Kuipers,et al. High cancer risk and increased mortality in patients with Peutz–Jeghers syndrome , 2011, Gut.
[59] F. Bosman,et al. WHO Classification of Tumours of the Digestive System , 2010 .
[60] Y. Bignon,et al. Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer , 2011, Cancer.
[61] D. Huntsman,et al. Hereditary diffuse gastric cancer , 2008, Cancer.
[62] B. Fernandez,et al. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. , 2015, JAMA oncology.
[63] M. Ligtenberg,et al. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour , 2004, Oncogene.
[64] Marvin B. Shapiro,et al. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.
[65] Xiao-mei Zhang,et al. Germline mutations and polymorphic variants in MMR, E‐cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China , 2006, International journal of cancer.
[66] C. Ki,et al. Presymptomatic Identification of CDH1 Germline Mutation in a Healthy Korean Individual with Family History of Gastric Cancer , 2014, Annals of laboratory medicine.
[67] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[68] V. Canzonieri,et al. Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer , 2013, PloS one.